BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 19035178)

  • 1. [Study on the relationship between human cytidine deaminase gene polymorphisms and Ara-C sensitivity].
    Chen XW; Yue LJ; Li CR; Li CG; Shi HS; Zhang M
    Zhonghua Xue Ye Xue Za Zhi; 2008 Jul; 29(7):459-63. PubMed ID: 19035178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Single-nucleotide polymorphisms of the cytidine deaminase gene in childhood with acute leukemia and normal Chinese children].
    Yue LJ; Chen XW; Li CR; Li CG; Shi HS; Zhang M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):699-702. PubMed ID: 18067088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A functional single-nucleotide polymorphism in the human cytidine deaminase gene contributing to ara-C sensitivity.
    Yue L; Saikawa Y; Ota K; Tanaka M; Nishimura R; Uehara T; Maeba H; Ito T; Sasaki T; Koizumi S
    Pharmacogenetics; 2003 Jan; 13(1):29-38. PubMed ID: 12544510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytidine deaminase genetic variants influence RNA expression and cytarabine cytotoxicity in acute myeloid leukemia.
    Abraham A; Varatharajan S; Abbas S; Zhang W; Shaji RV; Ahmed R; Abraham A; George B; Srivastava A; Chandy M; Mathews V; Balasubramanian P
    Pharmacogenomics; 2012 Feb; 13(3):269-82. PubMed ID: 22304580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of polymorphisms of cytosine arabinoside-metabolizing enzyme gene with therapeutic efficacy for acute myeloid leukemia.
    Xu PP; Chen BA; Feng JF; Cheng L; Xia GH; Li YF; Qian J; Ding JH; Lu ZH; Wang XM; Xu K; Schultz M
    Chin Med J (Engl); 2012 Jun; 125(12):2137-43. PubMed ID: 22884143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Polymorphisms of thymidylate synthase gene detected by RT-PCR-denaturing gradient gel electrophoresis in children with acute leukemia].
    Chen XW; Yue LJ; Li CG; Li CR; Zhang M; Shi HS
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Apr; 11(4):251-4. PubMed ID: 19374805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of resistance to cytosine arabinoside (Ara-C) in NALM-6 human B leukemia cells.
    Kanno S; Hiura T; Ohtake T; Koiwai K; Suzuki H; Ujibe M; Ishikawa M
    Clin Chim Acta; 2007 Feb; 377(1-2):144-9. PubMed ID: 17097625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to cytosine arabinoside by retrovirally mediated gene transfer of human cytidine deaminase into murine fibroblast and hematopoietic cells.
    Momparler RL; Eliopoulos N; Bovenzi V; Létourneau S; Greenbaum M; Cournoyer D
    Cancer Gene Ther; 1996; 3(5):331-8. PubMed ID: 8894252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant gene products of two natural variants of the human cytidine deaminase gene confer different deamination rates of cytarabine in vitro.
    Kirch HC; Schröder J; Hoppe H; Esche H; Seeber S; Schütte J
    Exp Hematol; 1998 May; 26(5):421-5. PubMed ID: 9590659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cytidine deaminase: a biochemical characterization of its naturally occurring variants.
    Micozzi D; Carpi FM; Pucciarelli S; Polzonetti V; Polidori P; Vilar S; Williams B; Costanzi S; Vincenzetti S
    Int J Biol Macromol; 2014 Feb; 63():64-74. PubMed ID: 24183806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between the expression of the genes encoding the key enzymes for cytarabine metabolism and the pharmacokinetics of cytarabine in the treatment of childhood acute leukemia with high-dose cytarabine].
    Xie XT; Jiang SY; Li BS; Yang LL
    Zhonghua Er Ke Za Zhi; 2008 Apr; 46(4):276-80. PubMed ID: 19099730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability in transport and biotransformation of cytarabine is associated with its toxicity in peripheral blood mononuclear cells.
    Parmar S; Seeringer A; Denich D; Gärtner F; Pitterle K; Syrovets T; Ohmle B; Stingl JC
    Pharmacogenomics; 2011 Apr; 12(4):503-14. PubMed ID: 21521023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mice transduced with double-mutant dihydrofolate reductase-cytidine deaminase fusion gene attained protection from high dose chemotherapy].
    Lu P; Lu Y; Pang K; Wang SB; Chen JQ; Xu HM; Wang JK; Zhao SC
    Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):998-1001. PubMed ID: 16194358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GATA1, cytidine deaminase, and the high cure rate of Down syndrome children with acute megakaryocytic leukemia.
    Ge Y; Stout ML; Tatman DA; Jensen TL; Buck S; Thomas RL; Ravindranath Y; Matherly LH; Taub JW
    J Natl Cancer Inst; 2005 Feb; 97(3):226-31. PubMed ID: 15687366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PCR-based methods for CDA K27Q and A70T genotyping: genotypes and alleles distribution in a central Italy population.
    Carpi FM; Vincenzetti S; Micozzi D; Vita A; Napolioni V
    Mol Biol Rep; 2010 Oct; 37(7):3363-8. PubMed ID: 19941076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydropyrimidine dehydrogenases and cytidine-deaminase gene polymorphisms as outcome predictors in resected gastric cancer patients treated with fluoropyrimidine adjuvant chemotherapy.
    Grau JJ; Caballero M; Monzó M; Muñoz-García C; Domingo-Domenech J; Navarro A; Conill C; Campayo M; Bombí JA
    J Surg Oncol; 2008 Aug; 98(2):130-4. PubMed ID: 18537153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of genetic alterations of cytarabine- metabolizing enzymes in childhood acute lymphoblastic leukemia.
    Banklau C; Jindadamrongwech S; Sawangpanich R; Apibal S; Hongeng S; Paisooksantivatana K; Pakakasama S
    Hematol Oncol Stem Cell Ther; 2010; 3(3):103-8. PubMed ID: 20890066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of 2-chlorodeoxyadenosine, arabinoside cytosine and doxorubicin on acute myeloid leukemia clonogenic cell proliferation].
    Sawiński K; Hansz J; Kozłowska-Skrzypczak M
    Acta Haematol Pol; 1995; 26(3):279-84. PubMed ID: 8525773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro sensitivity and cross-resistance to deoxynucleoside analogs in childhood acute leukemia.
    Hubeek I; Peters GJ; Broekhuizen R; Zwaan CM; Kaaijk P; van Wering ES; Gibson BE; Creutzig U; Janka-Schaub GE; den Boer ML; Pieters R; Kaspers GJ
    Haematologica; 2006 Jan; 91(1):17-23. PubMed ID: 16434366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ara-C metabolism: implications for drug resistance and drug interactions.
    Chabner BA; Hande KR; Drake JC
    Bull Cancer; 1979; 66(1):89-92. PubMed ID: 420952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.